Characteristics of Digital Health Studies Registered in ClinicalTrials.gov

Abstract

This analysis of digital health studies in ClinicalTrials.gov examines the clinical evidence underlying digital health interventions.

Conflict of interest statement

Conflict of Interest Disclosures: Dr. Chen reported being employed by Lyra Health and serving as a consultant for and having equity in Vida Health. Dr Harrington reported serving as a consultant for Adverse Events, Amgen, Bayer, Gilead, Merck & Co, Vida Health, and WebMD; performing data safety monitoring for AstraZeneca, BMS, and Janssen; having equity in Element Science and MyoKardia; having a fiduciary role in Scanadu, Signal Path, the American Heart Association, College of the Holy Cross, and Stanford Healthcare; and receiving research grants from CSL Behring, GlaxoSmithKline, Merck & Co, Novartis, Portola, Sanofi, and The Medicines Company. Dr Desai reported being employed by Apple. Dr. Mahaffey reported receiving research grants from Afferent, Amgen, Apple Inc, AstraZeneca, Cardiva Medical Inc, Daiichi Sankyo, Ferring, Google (Verily), Johnson & Johnson, Luitpold, Medtronic, Merck & Co, the National Institutes of Health, Novartis, Sanofi, St. Jude, and Tenax; serving as a consultant for Abbott, Ablynx, Baim Institute, Boehringer Ingelheim, Bristol-Myers Squibb, Cardiometabolic Health Congress, Elsevier, GlaxoSmithKline, Medergy, Medscape, Mitsubishi, MyoKardia, Novo Nordisk, Oculeve, Portola, Radiometer, Springer Publishing, Theravance, University of California San Francisco, and WebMD; and having equity in BioPrint Fitness. Dr Turakhia reported receiving research grants from Medtronic Inc, Research, Janssen Pharmaceuticals, AstraZeneca, the American Heart Association, and Amazon; serving as a consultant for Medtronic Inc and Abbott; and having equity in AliveCor. No other disclosures were reported.